Your shopping cart is currently empty

PD-1/PD-L1-IN-44 (Compound 22) selectively inhibits the PD-1/PD-L1 protein with an IC50 of 1.21 nM. In animal models, PD-1/PD-L1-IN-44 effectively suppressed tumor growth and increased CD8+ cell infiltration without exhibiting toxicity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PD-1/PD-L1-IN-44 (Compound 22) selectively inhibits the PD-1/PD-L1 protein with an IC50 of 1.21 nM. In animal models, PD-1/PD-L1-IN-44 effectively suppressed tumor growth and increased CD8+ cell infiltration without exhibiting toxicity. |
| In vitro | PD-1/PD-L1-IN-44 exhibits non-specific toxicity with an IC 50 value greater than 20 μM in MDA-MB231, H1299, HCT116, and A549 cell lines. At a concentration of 10 μM over 48 hours, PD-1/PD-L1-IN-44 effectively inhibits the proliferation of A549 cells in A549/PBMC T cell co-cultures, achieving an inhibition rate of up to 76.5%. |
| In vivo | PD-1/PD-L1-IN-44, administered at a dose of 10 mg/kg intraperitoneally (i.p.) once daily for 21 days, significantly inhibited tumor growth in 4T1 model mice. The formulation of the drug consists of 5% dimethyl sulfoxide, 10% castor oil, and 85% saline solution. |
| Formula | C34H30N2O6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.